Association between injection practices and duration of injection among recently initiated injection drug users

被引:49
作者
Buxton, MB
Vlahov, D
Strathdee, SA
Jarlais, DCD
Morse, EV
Ouellet, L
Kerndt, P
Garfein, RS
机构
[1] New York Acad Med, Ctr Urban Epidemiol Studies, New York, NY 10029 USA
[2] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA
[3] Beth Israel Med Ctr, Chem Dependency Unit, New York, NY 10003 USA
[4] Tulane Univ, New Orleans, LA 70117 USA
[5] Univ Illinois, Chicago, IL 60617 USA
[6] Los Angeles Cty Dept Hlth Serv, Los Angeles, CA 90012 USA
[7] Ctr Dis Control & Prevent, Div HIV AIDS, Atlanta, GA 30333 USA
关键词
injection drug users; HIV; epidemiology; risk factors;
D O I
10.1016/j.drugalcdep.2004.01.014
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: Earlier studies suggest higher infection risk among recently initiated injection drug users (IDUs) than more experienced users. Whether IDUs' risky injection practices rise progressively with duration of injection or frequency of practices is higher near initiation and then taper remains an open question. Methods: Recently initiated IDUs were street recruited and interviewed between 1997 and 1999 as part of a multisite cohort study in five US urban cities. Recent risky injection practices (injecting with others and injecting on average more now) were examined across three cross-sections defined by duration of injection: 0-1 year, 2-3 years, and 4-6 years. Results: The IDU groups of <2 years duration (n = 691) and 2-3 years duration (n = 697) had higher odds than the 4-6 year group (n = 520) of reporting injecting with others (Odds Ratio, OR = 1.52, and OR = 1.47, respectively) and injecting on average more now (OR = 1.44 and OR = 1.44, respectively). The associations remained after multivariate adjustment for demographic variables. Conclusions: These data on recently initiated IDUs suggest that risky injection practices were more frequent earlier than later within the first 6 years of initiation, emphasizing that outreach prevention needs to identify and intervene with IDUs early. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:177 / 183
页数:7
相关论文
共 24 条
[1]   HUMAN IMMUNODEFICIENCY VIRUS-INFECTION IN HETEROSEXUAL INTRAVENOUS-DRUG-USERS IN SAN-FRANCISCO [J].
CHAISSON, RE ;
MOSS, AR ;
ONISHI, R ;
OSMOND, D ;
CARLSON, JR .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1987, 77 (02) :169-172
[2]  
Diaz T, 2001, AM J PUBLIC HEALTH, V91, P23, DOI 10.2105/AJPH.91.1.23
[3]   Correlates of HIV infection among young adult short-term injection drug users [J].
Doherty, MC ;
Garfein, RS ;
Monterroso, E ;
Brown, D ;
Vlahov, D .
AIDS, 2000, 14 (06) :717-726
[4]   Viral infections in short-term injection drug users: The prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses [J].
Garfein, RS ;
Vlahov, D ;
Galai, N ;
Doherty, MC ;
Nelson, KE .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1996, 86 (05) :655-661
[5]   Prevalence and incidence of hepatitis C virus infection among young adult injection drug users [J].
Garfein, RS ;
Doherty, MC ;
Monterroso, ER ;
Thomas, DL ;
Nelson, KE ;
Vlahov, D .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1998, 18 :S11-S19
[6]  
GARTEN R, 2003, INT J EPIDEMIOL, V33, P1
[7]  
HECKATHORN D, 1996, 11 INT C AIDS VANC C
[8]   Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis [J].
Kral, AH ;
Bluthenthal, RN ;
Lorvick, J ;
Gee, L ;
Bacchetti, P ;
Edlin, BR .
LANCET, 2001, 357 (9266) :1397-1401
[9]   Differences in the incidence of hepatitis B and human immunodeficiency virus infections among injecting drug users [J].
Levine, OS ;
Vlahov, D ;
Brookmeyer, R ;
Cohn, S ;
Nelson, KE .
JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (03) :579-583
[10]  
MARMOR M, 1987, AIDS, V1, P39